Cost minimization analysis of a hexavalent vaccine in Argentina.

ABSTRACT:

Background

Argentina currently uses a pentavalent vaccine containing diphtheria, tetanus, pertussis (whole cell), Haemophilus influenza type b and hepatitis B antigens, administered concomitantly with the inactivated polio vaccine (IPV) (DTwP-Hib-HB plus IPV) in its childhood vaccination schedule. However, hexavalent vaccines containing acellular pertussis antigens (DTaP-Hib-HB-IPV) and providing protection against the same diseases are also licensed, but are only available with a private prescription or for high-risk pre-term infants in the public health program. We analyzed the cost of switching from the current schedule to the alternative schedule with the hexavalent vaccine in Argentina, assuming similar levels of effectiveness.

Methods

The study population was infants ≤

SUBMITTER: Olivera I 

PROVIDER: S-EPMC10557326 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature